Home
Latest Filings
Latest Buys
Latest Sells
Institutions
Derivatives
Hot Buys
Data Screener
Email Alerts
Insider Charts
NMIH
- As of 05/16/24, 08:32:29 AM: 18 Insider Transactions.
Sector:
Financial
Industry:
Surety & Title Insurance
Prev Close:
$5.71
Avg Vol(3m):
467,448
P/E:
0.00
EPS:
-0.41
Email this page to a friend.
Insider Transactions for NMIH
Buy/Sell*
Filed Date
Subject
Symbol
Acquirer
Pct Owned
Details
B
2020-09-10 12:01:01.0
KalVista Pharmaceuticals
KALV
FMR LLC
10.034%
view
S
2020-02-14 16:07:48.0
KalVista Pharmaceuticals
KALV
Venrock Healthcare Capital Partners II
5.7%
view
B
2020-02-13 12:45:19.0
KalVista Pharmaceuticals
KALV
EVENTIDE ASSET MANAGEMENT
9.4%
view
S
2019-04-18 18:35:52.0
KalVista Pharmaceuticals
KALV
RA CAPITAL MANAGEMENT
5.6%
view
S
2019-04-03 15:27:02.0
KalVista Pharmaceuticals
KALV
SVLSF IV
11.5%
view
B
2018-09-12 16:32:32.0
KalVista Pharmaceuticals
KALV
Vivo Ventures VI
12.3%
view
B
2018-08-09 16:33:24.0
KalVista Pharmaceuticals
KALV
Venrock Healthcare Capital Partners II
6.6%
view
B
2017-11-13 16:31:49.0
KalVista Pharmaceuticals
KALV
Longwood Fund II
8.7%
view
S
2017-10-16 10:59:02.0
KalVista Pharmaceuticals
KALV
Novo Holdings A
0.0%
view
B
2017-09-22 17:21:56.0
KalVista Pharmaceuticals
CBYL
SVLSF IV
26.6%
view
B
2017-02-14 16:26:39.0
KalVista Pharmaceuticals
CBYL
Vivo Ventures VI
16.0%
view
B
2017-02-07 14:51:49.0
KalVista Pharmaceuticals
CBYL
SVLSF IV
26.6%
view
S
2016-11-30 16:24:02.0
Carbylan Therapeutics
CBYL
PRICE T ROWE ASSOCIATES INC
1.7%
view
S
2016-04-11 09:57:07.0
Carbylan Therapeutics
CBYL
FMR LLC
10.2%
view
B
2016-02-12 09:01:23.0
Carbylan Therapeutics
CBYL
FMR LLC
5.5%
view
B
2015-05-11 14:17:50.0
Carbylan Therapeutics
CBYL
PRICE T ROWE ASSOCIATES INC
12.622%
view
B
2015-04-24 16:17:31.0
Carbylan Therapeutics
CBYL
Vivo Ventures VI
16.0%
view
B
2015-04-21 06:16:00.0
Carbylan Therapeutics
n/a
Broadfin Capital
5.2%
view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.